Abstract | PURPOSE: METHODS: We sought correlations between plasma apoM and PCSK9, measured using recently developed ELISAs, in 79 non-diabetic subjects. RESULTS: ApoM and PCSK9 levels were both correlated positively with total cholesterol, non- HDL cholesterol, LDL cholesterol and apoB (P < 0.05 to P < 0.001). ApoM correlated positively with PCSK9 in lean individuals (n = 37, r = 0.337, P = 0.041), but not in overweight subjects (n = 32, r = 0.125, P = 0.50) and in obese subjects (n = 10, r = -0.055, P = 0.88). CONCLUSIONS: The PCSK9 pathway may contribute to plasma apoM regulation in humans. The influence of PCSK9 on circulating apoM appears to be modified by adiposity.
|
Authors | Paul J W H Kappelle, Gilles Lambert, Björn Dahlbäck, Lars Bo Nielsen, Robin P F Dullaart |
Journal | Atherosclerosis
(Atherosclerosis)
Vol. 214
Issue 2
Pg. 492-4
(Feb 2011)
ISSN: 1879-1484 [Electronic] Ireland |
PMID | 21122852
(Publication Type: Letter, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2010. Published by Elsevier Ireland Ltd. |
Chemical References |
- APOM protein, human
- Apolipoproteins
- Apolipoproteins B
- Apolipoproteins M
- Biomarkers
- Cholesterol, LDL
- Lipocalins
- Cholesterol
- PCSK9 protein, human
- Proprotein Convertase 9
- Proprotein Convertases
- Serine Endopeptidases
|
Topics |
- Adiposity
- Aged
- Apolipoproteins
(blood)
- Apolipoproteins B
(blood)
- Apolipoproteins M
- Biomarkers
(blood)
- Body Mass Index
- Cholesterol
(blood)
- Cholesterol, LDL
(blood)
- Enzyme-Linked Immunosorbent Assay
- Humans
- Lipocalins
- Middle Aged
- Netherlands
- Obesity
(blood, physiopathology)
- Overweight
(blood, physiopathology)
- Proprotein Convertase 9
- Proprotein Convertases
- Regression Analysis
- Serine Endopeptidases
(blood)
|